We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

A Move Towards Precise Management of Bacterial Infections
Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

The Sequencing Technology Behind The World's Fastest Genetic Diagnosis
Blog

In February 2018, a team at Rady Children's Institute for Genomic Medicine broke the world record for the fastest genetic diagnosis when they delivered a rare disease diagnosis in just 19 hours 30 minutes. We caught up with John Reynders, CEO of Alexion, to discuss how the record was broken, and why diagnosing rare diseases is important in modern medicine.

Read More

The Digital Solutions Accelerating Scientific Discovery
Blog

Science advances at a rapid pace, and supporting technologies and infrastructures have to adapt accordingly. One of the latest evolutions in technology is the shift from traditional software and hardware tools to newer cloud-based services. In this blog, Thermo Fisher Scientific's Karen Velardi looks at, we look at the different cloud services that are changing the way modern research is done.

Read More

More Tools and More Time: An Easier Future for Bioinformaticians?
Blog

In the second of a two-part blog series, we talk with Genestack CEO Misha Kapushesky on the developments in Bioinformatics that he’s most excited about, and the latest modular additions to Genestack's bioinformatics platform.

Read More

Supporting the Development of Regenerative Medicines
Blog

Regenerative medicine is a branch of translational research which focuses on methods to regrow, repair or replace human cells, tissues or organs. We recently spoke with Michael May, President & CEO of CCRM, an organization supporting the development of regenerative medicines and associated technologies to learn more about their latest projects and collaborations.

Read More

Developing Bispecific Antibodies
Blog

Bispecific antibodies (bsAbs) harness the specificities of two antibodies and combine them to simultaneously recognize different antigens or epitopes. This ‘two-target’ functionality has meant that interest in their use for therapeutic applications has increased considerably. We spoke to GenScript’s Liusong Yin, PhD, and Jie Ma, to learn more about bispecific antibodies and the associated challenges developing them.

Read More

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
Blog

During this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.

Read More

Targeting Cancer’s Metabolic Vulnerability
Blog

Cancer cells are able to evolve to depend on two metabolic processes, glycolysis and oxidative phosphorylation. We spoke to Phil Jones from The University of Texas MD Anderson Cancer Center, to learn about the discovery and development of IACS-10759, identified as as a viable oxidative phosphorylation inhibitor.

Read More

Are Modular Approaches The Way Forward for Bioinformatics?
Blog

In the first of a two-part blog series, we discuss the advantages of a modular approach to bioinformatics with Dr. Misha Kapushesky, CEO and Founder of Genestack. Perviously a Team Leader at the European Bioinformatics Institute, we also learn about Misha's move from Institute to industry.

Read More

Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward
Blog

We recently spoke to GenScript’s VP of Marketing, Eric Wang, to learn more about the company’s mission to “make people and nature healthier through biotechnology”. Eric discusses the key phases of antibody therapeutic discovery and development, GenScript’s role in advancing drug discovery research, and tells us about the company’s recently launched custom rabbit monoclonal antibody service.

Read More